BeyondSpring Inc (NASDAQ: BYSI) has experienced a rise in its stock price by 30.00 compared to its previous closing price of 1.70. However, the company has seen a gain of 35.58% in its stock price over the last five trading days. globenewswire.com reported 2025-06-03 that FLORHAM PARK, N.J., June 03, 2025 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing cancer therapies, today announces that it presented interim phase 2 data on the 303 Study, a study in 2L/3L non-small cell lung cancer (NSCLC) after disease progression on 1L PD-1/L1 inhibitors with and without chemotherapy (NCT05599789), with financial support from Merck’s (Rahway, NJ USA) Investigator Studies Program and provision of study drug, at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, on May 31st, 2025 in Chicago, IL.
Is It Worth Investing in BeyondSpring Inc (NASDAQ: BYSI) Right Now?
The 36-month beta value for BYSI is also noteworthy at 0.08. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for BYSI is 29.31M, and at present, short sellers hold a 6.28% of that float. The average trading volume of BYSI on June 10, 2025 was 19.56K shares.
BYSI’s Market Performance
The stock of BeyondSpring Inc (BYSI) has seen a 35.58% increase in the past week, with a 24.16% rise in the past month, and a 33.94% gain in the past quarter. The volatility ratio for the week is 13.14%, and the volatility levels for the past 30 days are at 6.61% for BYSI. The simple moving average for the past 20 days is 28.62% for BYSI’s stock, with a 22.52% simple moving average for the past 200 days.
Analysts’ Opinion of BYSI
Many brokerage firms have already submitted their reports for BYSI stocks, with Jefferies repeating the rating for BYSI by listing it as a “Hold.” The predicted price for BYSI in the upcoming period, according to Jefferies is $5 based on the research report published on December 02, 2021 of the previous year 2021.
BofA Securities, on the other hand, stated in their research note that they expect to see BYSI reach a price target of $5, previously predicting the price at $45. The rating they have provided for BYSI stocks is “Underperform” according to the report published on December 02nd, 2021.
BYSI Trading at 40.50% from the 50-Day Moving Average
After a stumble in the market that brought BYSI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.69% of loss for the given period.
#####
#####
Stock Fundamentals for BYSI
Current profitability levels for the company are sitting at:
- 14.95 for the present operating margin
- 1.0 for the gross margin
The net margin for BeyondSpring Inc stands at -0.47. The total capital return value is set at -0.27.
Based on BeyondSpring Inc (BYSI), the company’s capital structure generated -0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -37.73.
Currently, EBITDA for the company is -8.48 million with net debt to EBITDA at 0.83. When we switch over and look at the enterprise to sales, we see a ratio of -189.77. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.49.
Conclusion
In summary, BeyondSpring Inc (BYSI) has had a better performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
